Valeant

» Auto updated continuously

Display limited to 'Valeant' in document titles and meta descriptions. Display In Whole Documents or use the calendar above to adjust the date setting.

 2018-01-17 02:37 

NY Post

Ackman reaches $290M settlement with Valeant...

Bill Ackman and Valeant Pharmaceuticals can breathe a sigh of relief — for now. A federal judge in California indicated Tuesday that he would grant preliminary approval to a $290 million settlement Ackman's Pershing Square and Valeant reached wi...

 2018-01-16 23:17 

Fox Business

Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant -- Update...

A federal judge signaled Tuesday he would approve a $290 million settlement reached by Pershing Square Capital Management, Valeant Pharmaceuticals International Inc. and the shareholders of Allergan PLC who had alleged the two firms improperly profited fr...

 2018-01-16 22:42 

CTV News

Valeant says California judge gives preliminary approval to Allergan settlement...

Valeant Pharmaceuticals International Inc. says a U.S. District Court judge gave his preliminary approval Tuesday to a US$290-million settlement of lawsuits stemming from the unsuccessful attempted hostile takeover in 2014 of Botox maker Allergan Inc....

 2018-01-16 22:24 

Globe and Mail

Valeant says judge gives preliminary approval to Allergan settlement...

As part of the deal agreed to in December, Quebec-based Valeant will pay $96.25 million, with co-defendant Pershing Square Capital Management, L.P. paying the rest...

 2018-01-16 21:54 

Fox Business

Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant...

A federal judge signaled Tuesday he would approve a $290 million settlement reached by Pershing Square Capital Management, Valeant Pharmaceuticals International Inc. and the shareholders of Allergan PLC who had alleged the two firms improperly profited fr...

 2018-01-16 21:42 

Wall Street Journal

Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant...

A federal judge signaled he would approve a $290 million settlement reached by Pershing Square, Valeant and the shareholders of Allergan who had alleged the two firms improperly profited from their failed attempt to buy the maker of Botox....

 2018-01-12 12:06 

Reuters

BRIEF-Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121...

Valeant Pharmaceuticals International Inc:...

 2018-01-11 19:36 

Business Insider

How a tiny company brought the first 'female Viagra' to market against all odds - CLONE...

Sprout Pharmaceuticals' CEO Cindy Whitehead had a busy week....

 2018-01-10 20:57 

The Street

Valeant CEO: Drugmaker Knee-Deep in 'Turnaround Effort of a Lifetime'...

With the stock of the drugmaker hovering around $23 a share and its reputation bloodied, CEO Joe Papa tried to explain his company's comeback efforts to investors....

 2018-01-10 20:40 

Bloomberg

Valeant CEO Is in the Midst of the 'Turnaround Opportunity of a Lifetime'...

Valeant Pharmaceuticals International Inc. became a household name with its historic rise and fall. Reviving the drugmaker is proving a unique challenge....

 2018-01-10 20:06 

Washington Post

Valeant's 'Significant Seven' Aren't Quite Magnificent: Gadfly...

Dontget too close -- you might scare them -- but Valeant Pharmaceuticals International Inc. shares are up more than 50 percent over the past two months....

 2018-01-09 19:50 

CNBC

Valeant CEO looks to boost performance with price hikes and seven key products...

Valeant CEO Joe Papa projects price hikes on drugs and $1 billion portfolio of new products will help the drugmaker fight debt and exclusivity challenges....

 2018-01-09 17:24 

Fool.com

Valeant Pharmaceuticals' Stellar 43% Gain in 2017, Explained...

Wall Street rewards the embattled Valeant after the company met numerous goals last year....

 2018-01-09 12:25 

Reuters

[ UK ]

BRIEF-Valeant Says Seven Key Products Are Projected To Generate $1 Bln In Sales In 5 Years...

Valeant Pharmaceuticals International Inc :...

 2018-01-09 12:25 

Reuters

BRIEF-Valeant Says Seven Key Products Are Projected To Generate $1 Bln In Sales In 5 Years...

Valeant Pharmaceuticals International Inc:...

 2018-01-08 13:15 

Reuters

BRIEF-Valeant says Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite Vision Enhancement System...

Valeant Pharmaceuticals International Inc:...

 2018-01-05 15:33 

Fool.com

3 Compelling Reasons Valeant Pharmaceuticals Exploded Higher by 24% in December...

Valeant took another step forward on its road to redemption, but it still has a long walk ahead....

 2018-01-03 14:53 

Fox Business

Valeant Cuts Debt Load to $25.7 Billion at End of 2017...

Valeant Pharmaceuticals International Inc. (VRX) on Wednesday said it paid down another $300 million of its senior secured term loans, paring its debt load to about $25.7 billion at the end of 2017....

 2018-01-03 14:01 

Reuters

BRIEF-Valeant Pays Down $300 Million Of Senior Secured Term Loans...

Valeant Pharmaceuticals International Inc:...

 2018-01-03 11:17 

Globe and Mail

Valeant, Pershing Square to appear in court on insider trading suit settlement...

The hearing, set for Jan. 16, comes after Pershing Square and Valeant last week decided to pay $290-million to settle the lawsuit...

 2018-01-03 05:54 

Fox Business

Pershing Square, Valeant to appear in court on insider trading suit settlement...

A U.S. court on Tuesday asked Valeant Pharmaceuticals International and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit....

 2018-01-03 05:34 

Reuters

[ UK ]

Pershing Square, Valeant to appear in court on insider trading suit settlement...

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit....

 2018-01-03 05:33 

Reuters

Pershing Square, Valeant to appear in court on insider trading suit settlement...

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc (VRX.TO) and activist investor Bill Ackman's Pershing Square (PSH.AS) to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit....

 2018-01-03 05:33 

Reuters

[ UK ]

Pershing Square, Valeant to appear in court on insider trading suit settlement...
 2018-01-03 05:33 

Reuters

UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement...
 2018-01-03 05:33 

Reuters

[ UK ]

UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement...
 2018-01-03 04:47 

Business Insider

Pershing Square, Valeant asked to appear for hearing on insider trading suit...

Jan 2 (Reuters) - A U.S. court on Tuesday asked......

 2018-01-03 04:30 

Channel NewsAsia

Pershing Square, Valeant asked to appear for hearing on insider trading suit...
 2018-01-03 04:25 

One America News Network

Pershing Square, Valeant asked to appear for hearing on insider trading suit...

- A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the...

 2018-01-03 04:24 

Reuters Canada

Pershing Square, Valeant asked to appear for hearing on insider trading suit...

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc VRX.TO and activist investor Bill Ackman's Pershing Square PSH.AS to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit....

 2018-01-03 04:24 

Reuters

Pershing Square, Valeant asked to appear for hearing on insider trading suit...

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc (VRX.TO) and activist investor Bill Ackman's Pershing Square (PSH.AS) to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit....

 2018-01-03 04:19 

Reuters

Pershing Square, Valeant asked to appear for hearing on insider trading suit...
 2018-01-03 02:52 

NY Post

Judge has questions for Ackman about proposed settlement...

Just when he thought he was out, hedgie Bill Ackman is being pulled back into his disastrous Valeant Pharmaceuticals relationship by a California judge. The judge on Tuesday said that he has "substantial questions" about the $290 million settlemen...

 2017-12-30 05:00 

Forbes

Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 Million...

Hedge funder Bill Ackman and Valeant Pharmaceuticals will pay $290 million to settle claims from shareholders in Allergan they engaged in insider trading when pressing a takeover of the botox-maker in 2014. The settlement means Valeant likely cost Pershin...

 2017-12-30 00:15 

Fox Business

News Highlights: Top Company News of the Day...

Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoi...

 2017-12-29 22:52 

Financial Times

Ackman agrees $194m settlement over Allergan suit...

Pershing Square and Valeant were accused of improper trading ahead of 2014 bid for Botox maker...

 2017-12-29 22:15 

Fox Business

News Highlights: Top Company News of the Day...

Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoi...

 2017-12-29 22:15 

Montreal Gazette

Valeant strikes deal to reduce its portion of Allergan settlement to $96.25M...

Both companies say they are admitting no wrongdoing by settling....

 2017-12-29 21:32 

CTV News

Valeant strikes deal to cut its portion of Allergan settlement to $96.25M...

Valeant Pharmaceuticals International, Inc. says it has agreed to pay US$96.25 million to settle lawsuits filed in California in the wake of the unsuccessful attempted hostile takeover in 2014 of Botox maker Allergan Inc....

 2017-12-29 21:25 

National Post

Valeant strikes deal to reduce its portion of Allergan settlement to $96.25M...

LAVAL, Que. — Valeant Pharmaceuticals International, Inc. (TSX:VRX) says it has agreed to pay US$96.25 million to settle lawsuits filed in California in the wake of the unsuccessful attempted hostile takeover in 2014 of Botox maker Allergan Inc. The...

 2017-12-29 21:00 

Reuters

[ UK ]

Deals of the day-Mergers and acquisitions...

(Adds Turkey, Valeant,IAG and Hopewell; Updates Rosneft)...

 2017-12-29 20:18 

Fox Business

News Highlights: Top Company News of the Day...

Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoi...

 2017-12-29 19:27 

Business Insider

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...

(Reuters) - Activist investor William Ackman's......

 2017-12-29 19:20 

Channel NewsAsia

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...
 2017-12-29 19:20 

One America News Network

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...

- Activist investor William Ackman's Pershing Square and Valeant Pharmaceuticals on Friday decided to pay $290 million to settle a lawsuit that accused them of insider...

 2017-12-29 19:17 

Globe and Mail

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...

Pershing Square said Valeant will now pay around 33 per cent, or $96.25-million, of the settlement costs...

 2017-12-29 19:16 

Reuters Canada

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...

Activist investor William Ackman's Pershing Square PHS.AS and Valeant Pharmaceuticals VRX.TO on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc AGN.N in 2014....

 2017-12-29 19:16 

Reuters

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...

Activist investor William Ackman's Pershing Square PHS.AS and Valeant Pharmaceuticals (VRX.TO) on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc (AGN.N) in 2014....

 2017-12-29 19:14 

Reuters

UPDATE 1-Pershing Square, Valeant arrive at settlement split for Allergan lawsuit...
 2017-12-29 18:28 

Bloomberg

Pershing Square, Valeant to Pay $290 Million to End Insider Suit...

Activist investor Bill Ackmans Pershing Square Holdings Ltd. and Valeant Pharmaceuticals International Inc. agreed to pay $290 million to settle investor claims that they engaged in insider trading in the unsuccessful 2014 takeover bid for botox-maker All...

Page 1 of 2

  • Need an account?  
    or